Kurser indlæses...
Prognose
Vi har ingen analytikerdata for denne virksomhed.
Nyheder Til nyhedsfeedet
DocCheck reports preliminary 2025 results: revenue and EBIT rise
DocCheck expects 2025 revenue of between €55.1 million and €55.4 million (previous year: €53.8 million) and EBIT of €7.8 million to €8.1 million (previous year: €6.6 million), putting EBIT above the most recently adjusted forecast. The cause is a better-than-expected business performance in the fourth quarter of 2025. Cash and cash equivalents fell to €14.5 million (previous year: €17.0 million); earnings per share cannot yet be quantified. For 2026 the company expects organic growth in an economically challenging environment. » Mere på finanzen.net
DocCheck reports preliminary nine-month figures: revenue and EBIT increased
The DocCheck Group generated revenue of €39.7 million in the first nine months of 2025 (previous year: €37.5 million) and an EBIT of €5.5–5.8 million (previous year: €3.5 million). The revenue forecast for 2025 remains €50.0–55.0 million, while the earnings forecast was raised from €5.0–5.5 million to €6.5–6.8 million. Liquid funds amounted to €14.9 million at the reporting date (previous year: €15.8 million); statements on earnings per share are not yet possible. » Mere på finanzen.net
Historisk udbytte Udbytte
Alle nøgletal for udbytte Alle nøgletalVirksomhedstal
| (EUR) | juni 2026 | YoY |
|---|---|---|
| Omsætning | 27,88 mio. | - |
| Bruttofortjeneste | 4,19 mio. | - |
| Nettoresultat | 1,79 mio. | - |
| EBITDA | 4,11 mio. | - |
Fundamentale data
| Nøgletal | Værdi |
|---|---|
Markedsværdi | 53,28 mio. € |
Antal aktier | 5,07 mio. |
Højeste/laveste i 52 uger | 15,90 € - 10,20 € |
Udbytteafkast | 9,43 % |
Udbytte TTM | 1,00 € |
Beta | 0,90 |
P/E (PE Ratio) | 11,41 |
PEG (PEG Ratio) | -0,57 |
K/I (PB Ratio) | 1,39 |
P/S (PS Ratio) | 0,94 |
Virksomhedsprofil
DocCheck AG tilbyder marketing-, kundeforholdsstyrings- og e-handelsydelser til sundhedssektoren i Europa. Virksomheden driver DocCheck-portalen til udveksling af information på internettet samt online- og e-handelsydelser til aktører på sundhedsmarkedet. Den udvikler og implementerer også kommunikationsstrategier for nye og traditionelle medier inden for sundheds- og business-to-business-sektorerne og fremmer sundhedsstartups gennem seed-finansiering. DocCheck AG har hjemsted i Köln, Tyskland.
| Navn | DocCheck |
| CEO | Frank Nicolas Antwerpes |
| Hjemsted | Cologne,
nw Tyskland |
| Websted | |
| Sektor | Informationsteknologi |
| Branche | IT-tjenester |
| Børsnotering | 17.04.2020 |
| Medarbejdere | 414 |
Deep Dive
Tickersymboler
| Børs | Symbol |
|---|---|
XETRA | AJ91.DE |
Frankfurt | AJ91.F |
Düsseldorf | AJ91.DU |
SIX | AJ91.SW |
München | AJ91.MU |
